FRANKLIN LAKES, N.J., April 13, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its BD MAX™ Molecular Multi-Drug ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics portfolio in Europe. This follows the ...

BD MAX SYSTEM for BD MAX MRSA assay by Becton Dickinson BD Diagnostics announced that it has received FDA approval to market BD MAX MRSA molecular test, a new test that is designed to rapidly and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Becton Dickinson’s Diagnostics operation received FDA clearance to market the BD MAX™ MRSA molecular test. The assay is carried out on the automated BD MAX system, and is designed to rapidly identify ...

BD Diagnostics, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), announced today the availability of the FDA-cleared BD MAX™ Enteric Bacterial ...

New Delhi: To enable clinicians to rapidly test for Tuberculosis (TB) and multi-drug resistance as a first-line test, BD Diagnostics, a segment of BD Lifesciences introduced the BD MAX molecular ...

A search of the Medicines and Healthcare Products Regulatory Agency website revealed no manufacturer Field Safety Notices or Medical Device Alerts for this device. No reports of adverse events were ...

This briefing describes the regulated use of the technology for the indication specified, in the setting described, and with any other specific equipment referred to. It is the responsibility of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...